Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

ClinicalTrials.gov ID: NCT06008756

Public ClinicalTrials.gov record NCT06008756. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 31, 2026, 9:04 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascular Events in Participants at High Cardiovascular Risk

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase 3, randomized, placebo-controlled study of the efficacy and safety of enlicitide decanoate, an oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, in participants with high cardiovascular risk. The primary objective is to evaluate the efficacy of enlicitide decanoate compared with placebo in increasing the time to the first occurrence of major adverse cardiovascular events (MACE) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb ischemia or major amputation, or urgent arterial revascularization.

Study identification

NCT ID
NCT06008756
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
14,550 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 9, 2023 (Actual)
Primary completion
Nov 29, 2029 (Estimated)
Completion
Nov 29, 2031 (Estimated)
Last update posted
Apr 23, 2026

2023 – 2031

United States locations

U.S. sites
132
U.S. states
38
U.S. cities
116
Facility City State ZIP Site status
Advanced Cardiovascular - Alexander City ( Site 0156) Alexander City Alabama 35010 —
Central Research Associates ( Site 0118) Birmingham Alabama 35205 —
St. Vincent's Birmingham Hospital ( Site 0181) Birmingham Alabama 35205 —
Central Alabama Research ( Site 0109) Birmingham Alabama 35209 —
Alliance for Multispecialty Research, LLC ( Site 0076) Daphne Alabama 36526 —
G&L Research ( Site 0042) Foley Alabama 36535 —
NextStage Clinical Research - Phoenix - (01) ( Site 0191) Glendale Arizona 85306 —
Synexus Clinical Research US, Inc.-Synexus Clinical Research US, Inc - Central Phoenix ( Site 0066) Phoenix Arizona 85020 —
Medical Investigations Inc. ( Site 0188) Little Rock Arkansas 72211 —
National Heart Institute-Research ( Site 0077) Beverly Hills California 90211 —
UCSD - Altman Clinical and Translational Research Institute (ACTRI) ( Site 0130) La Jolla California 92037 —
Chemidox Clinical Trials ( Site 0145) Lancaster California 93534 —
Velocity Clinical Research, Westlake ( Site 0039) Los Angeles California 90057 —
Carbon Health - Pasadena ( Site 0149) Pasadena California 91101 —
Carbon Health - San Mateo - Hillsdale Mall ( Site 0151) San Mateo California 94403 —
America Clinical Trials-Research Dept ( Site 0104) Tarzana California 91356-3551 —
Premiere Medical Center ( Site 0093) Toluca Lake California 91602 —
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center ( Site 0058) Torrance California 90502 —
University of Colorado Anschutz Medical Campus-University of Colorado Hospital Cardiac and Vascular ( Site 0146) Aurora Colorado 80045 —
South Denver Cardiology Associates ( Site 0167) Littleton Colorado 80120 —
Cardiology Associates of Fairfield County, P.C. ( Site 0159) Stamford Connecticut 06905 —
Chase Medical Research, LLC ( Site 0046) Waterbury Connecticut 06708 —
Emerson Clinical Research Institute ( Site 0143) Washington D.C. District of Columbia 20009 —
Excel Medical Clinical Trials ( Site 0052) Boca Raton Florida 33434 —
Advanced Pharma Research ( Site 0040) Cutler Bay Florida 33189 —
Alliance for Multispecialty Research, LLC ( Site 0083) Fort Myers Florida 33912 —
Westside Center for Clinical Research ( Site 0049) Jacksonville Florida 32205 —
University of Florida - Jacksonville ( Site 0166) Jacksonville Florida 32209 —
East Coast Institute for Research, LLC ( Site 0031) Jacksonville Florida 32216 —
Jacksonville Center for Clinical Research ( Site 0048) Jacksonville Florida 32216 —
East Coast Institute for Research ( Site 0034) Lake City Florida 32055 —
Columbus Clinical Services ( Site 0026) Miami Florida 33125 —
Miami Cardiac & Vascular Institute-Ambulatory Research ( Site 0059) Miami Florida 33173 —
Inpatient Research Clinic ( Site 0041) Miami Lakes Florida 33014 —
Eminat ( Site 0082) Miramar Florida 33027 —
Ocala Research Institute - Ocala - Southwest 20th Place ( Site 0079) Ocala Florida 34471 —
Progressive Medical Research ( Site 0045) Port Orange Florida 32127 —
St Johns Center for Clinical Research ( Site 0016) Saint Augustine Florida 32086 —
Clinical Site Partners LLC, dba CSP Orlando ( Site 0067) Winter Park Florida 32789 —
The Jones Center Clinical Research ( Site 0032) Macon Georgia 31210 —
North Georgia Clinical Research ( Site 0128) Woodstock Georgia 30189 —
Bingham Memorial Hospital ( Site 0195) Blackfoot Idaho 83221 —
Synexus Clinical Research US, Inc. ( Site 0084) Chicago Illinois 60602 —
Great Lakes Clinical Trials - Ravenswood ( Site 0056) Chicago Illinois 60640 —
Great Lakes Clinical Trials - Gurnee ( Site 0134) Gurnee Illinois 60031 —
Alliance for Multispecialty Research, LLC ( Site 0173) Park Ridge Illinois 60068 —
Healthcare Research Network - Chicago ( Site 0051) Tinley Park Illinois 60477 —
Alliance for Multispecialty Research - Medisphere Medical Research Center ( Site 0080) Evansville Indiana 47714 —
Parkview Research Center at Parkview Regional Medical Center ( Site 0154) Fort Wayne Indiana 46845 —
Franciscan Physician Network - Indiana Heart Physicians ( Site 0141) Indianapolis Indiana 46237 —
Reid Physician Associates ( Site 0174) Richmond Indiana 47374 —
University of Kansas Medical Center ( Site 0004) Kansas City Kansas 66160 —
Cotton O'Neil Clinical Research Center ( Site 0095) Topeka Kansas 66606 —
AMR Clinical - Wichita ( Site 0116) Wichita Kansas 67226 —
Alliance for Multispecialty Research, LLC ( Site 0027) Lexington Kentucky 40509 —
L-MARC Research Center ( Site 0001) Louisville Kentucky 40213 —
Avant Research Associates ( Site 0103) Crowley Louisiana 70526 —
IMA Clinical Research- Monroe- North 18th Street ( Site 0111) Monroe Louisiana 71201 —
Northeast Cardiology Associates ( Site 0168) Bangor Maine 04401 —
Flourish Research - Bowie ( Site 0190) Bowie Maryland 20715 —
Centennial Medical Group ( Site 0179) Columbia Maryland 21045 —
Brigham and Women's Hospital-Cardiovascular Medicine ( Site 0147) Boston Massachusetts 02115 —
Boston Clinical Trials ( Site 0029) Boston Massachusetts 02131 —
Alliance for Multispecialty Research, LLC. ( Site 0171) Dearborn Michigan 48126 —
Healthy Heart Cardiology ( Site 0113) Grand Rapids Michigan 49546 —
Arcturus Healthcare , PLC, Troy Internal Medicine Research Division ( Site 0003) Troy Michigan 48098 —
Trinity Health-Michigan d/b/a Michigan Heart ( Site 0186) Ypsilanti Michigan 48197 —
Fairview Health Services ( Site 0024) Maplewood Minnesota 55109 —
Abbott Northwestern Hospital ( Site 0199) Minneapolis Minnesota 55407 —
University of Minnesota, Lillehei Clinical Research Unit ( Site 0193) Minneapolis Minnesota 55455 —
Velocity Clinical Research, Gulfport ( Site 0038) Gulfport Mississippi 39503 —
Cardiology Associates of North Mississippi ( Site 0169) Tupelo Mississippi 38801 —
Healthcare Research Network - St. Louis ( Site 0053) Hazelwood Missouri 63042 —
Alliance for Multispecialty Research, LLC ( Site 0071) Kansas City Missouri 64114 —
Skyline Medical Center/CCT Research ( Site 0148) Elkhorn Nebraska 68022 —
Velocity Clinical Research at The Pioneer Heart Institute, Lincoln ( Site 0078) Lincoln Nebraska 68510 —
CHI Health Clinic Heart Institute ( Site 0180) Lincoln Nebraska 68526 —
Excel Clinical Research, LLC ( Site 0123) Las Vegas Nevada 89109 —
Clinical Research of South Nevada ( Site 0135) Las Vegas Nevada 89121-4350 —
Advanced Heart Care - Bridgewater Route 22 ( Site 0160) Bridgewater New Jersey 08807 —
Cardiovascular Associates of the Delaware Valley ( Site 0162) Washington Township New Jersey 08080 —
New Mexico Clinical Research & Osteoporosis Center ( Site 0005) Albuquerque New Mexico 87106 —
Velocity Clinical Research, Binghamton ( Site 0063) Binghamton New York 13905 —
Central New York Clinical Research ( Site 0044) Manlius New York 13104 —
North Shore Diabetes & Endocrine Associates ( Site 0165) New Hyde Park New York 11042 —
Mid Hudson Medical Research ( Site 0087) New Windsor New York 12553 —
NYU Langone Health ( Site 0099) New York New York 10016 —
Rochester Clinical Research, Inc. ( Site 0098) Rochester New York 14609 —
Laurelton Heart Specialist PC ( Site 0092) Rosedale New York 11422 —
Duke University Health System (DUHS) ( Site 0153) Durham North Carolina 27710 —
Wake Forest Baptist Health-Cardiovascular Medicine ( Site 0142) Winston-Salem North Carolina 27157 —
Lillestol Research ( Site 0025) Fargo North Dakota 58104 —
Altru Health System ( Site 0197) Grand Forks North Dakota 58201 —
Velocity Clinical Research, Springdale ( Site 0112) Cincinnati Ohio 45246 —
Cleveland Clinic Main ( Site 0121) Cleveland Ohio 44195 —
The Ohio State Wexner Medical Center ( Site 0200) Columbus Ohio 43203 —
Remington-Davis, Inc. ( Site 0183) Columbus Ohio 43215 —
Premier Cardiovascular Institute ( Site 0136) Dayton Ohio 45414 —
Genesis Healthcare System-Pharmacy Research ( Site 0163) Zanesville Ohio 43701 —
South Oklahoma Heart Research ( Site 0164) Oklahoma City Oklahoma 73135 —
Capital Area Research, LLC ( Site 0139) Camp Hill Pennsylvania 17011 —
Guthrie Medical Group, P.C. ( Site 0176) Sayre Pennsylvania 18840 —
Cardiology Consultants of Philadelphia Yardley ( Site 0072) Yardley Pennsylvania 19067 —
Velocity Clinical Research, Anderson ( Site 0022) Anderson South Carolina 29621 —
Coastal Carolina Research Center ( Site 0006) North Charleston South Carolina 29405 —
Monument Health Clinical Research, a department of Monument -Monument Health Clinical Research, a d ( Site 0009) Rapid City South Dakota 57701 —
Holston Medical Group ( Site 0106) Bristol Tennessee 37620 —
Holston Medical Group ( Site 0047) Kingsport Tennessee 37660 —
Alliance for Multispecialty Research, LLC ( Site 0008) Knoxville Tennessee 37909 —
PharmaTex Research, LLC ( Site 0182) Amarillo Texas 79106 —
Texas Diabetes and Endocrinology, P.A. ( Site 0187) Austin Texas 78731 —
Southwest Family Medicine Associates ( Site 0189) Dallas Texas 75235 —
Prolato Clinical Research Center ( Site 0108) Houston Texas 77054 —
Permian Research Foundation ( Site 0157) Odessa Texas 79761 —
LinQ Research ( Site 0101) Pearland Texas 77584 —
Northeast Clinical Research of San Antonio ( Site 0011) San Antonio Texas 78233 —
Discovery Clinical Trials ( Site 0096) San Antonio Texas 78258 —
Sugar Lakes Family Practice, PA ( Site 0094) Sugar Land Texas 77479 —
LinQ Research - Tomball ( Site 0208) Tomball Texas 77375 —
Northwest Houston Heart Center-Northwest Houston Clinical Research, PLLC ( Site 0158) Tomball Texas 77375 —
NextStage Clinical Research - Waco ( Site 0196) Waco Texas 76712 —
Synexus Clinical Research US, Inc. ( Site 0086) Salt Lake City Utah 84106 —
Highland Clinical Research ( Site 0122) Salt Lake City Utah 84124 —
Velocity Clinical Research, Salt Lake City ( Site 0019) West Jordan Utah 84088 —
Burke Internal Medicine and Research ( Site 0035) Burke Virginia 22015 —
Charlottesville Medical Research ( Site 0030) Charlottesville Virginia 22911 —
Virginia Heart ( Site 0097) Falls Church Virginia 22042 —
Carient Heart & Vascular - Manassas ( Site 0170) Manassas Virginia 20109 —
Manassas Clinical Research Center ( Site 0007) Manassas Virginia 20110 —
Health Research of Hampton Roads, Inc. ( Site 0043) Newport News Virginia 23606 —
Alliance for Multispecialty Research, LLC ( Site 0068) Norfolk Virginia 23502 —
Centricity Research Suffolk Family Medicine ( Site 0105) Suffolk Virginia 23435 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 537 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06008756, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 23, 2026 · Synced Oct 31, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06008756 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →